To provide an initial insight into the cellular mechanism of action, we profiled the production of immune factors from CT-2A cells that were cocultured with splenocytes derived from mice cured of intracranial CT-2A tumours using combined SMC and anti-PD-1 treatment. The gene discussed is PDCD1; the disease is neoplasm.